Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Santaguida, P. L.
space
  arrow  Raina, P.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

CHALLENGES OF SUMMARIZING BETTER INFORMATION FOR BETTER HEALTH: THE EVIDENCE-BASED PRACTICE CENTER EXPERIENCE

Mark Helfand, MD, MPH; Sally Morton, PhD; Eliseo Guallar, MD, PhD; and Cynthia Mulrow, MD, MSc, Editors

Challenges in Systematic Reviews That Evaluate Drug Efficacy or Effectiveness

right arrow P. Lina Santaguida, PhD; Mark Helfand, MD, MPH; and Parminder Raina, PhD

21 June 2005 | Volume 142 Issue 12 Part 2 | Pages 1066-1072

Increasingly, consumers, clinicians, regulatory bodies, and insurers are using systematic reviews of drug interventions to select treatments and set policies. Although a systematic review cannot provide all the information a clinician needs to make an informed choice for therapy, it can help decision makers distinguish what claims about effectiveness are based on evidence, identify critical information gaps, desc ribe features of the evidence that limit applicability in practice, and address whether drug effectiveness differs for particular subgroups of patients. To improve the relevance and validity of reviews of drug therapies, reviewers need to delineate clinically important subgroups, specific aims of therapy, and most important outcomes. They may need to find unpublished trials, studies other than direct comparator (head-to-head) trials, and additional details of published trials from pharmaceutical manufacturers and regulatory agencies. In this paper, we address ways to formulate questions relevant to specific clinical therapeutic aims; discuss types of studies to include in drug efficacy and effectiveness reviews and how to find them; and describe ways to assess applicability of studies to actual practice.

Author and Article Information
space

From McMaster University Evidence-based Practice Centre, Hamilton, Ontario, Canada; and Portland Veterans Affairs Medical Center and Oregon Health & Science University Evidence-based Practice Center, Portland, Oregon.

Grant Support: This research was performed under contract to the Agency for Healthcare Research and Quality (contract 290-97-0017), Rockville, Maryland. Dr. Raina holds a Canadian Institutes of Health Research (CIHR) Investigator Award and a Premier's Excellence Award (PREA) from the Ontario Provincial Government.

Potential Financial Conflicts of Interest: Authors of this paper have received funding for Evidence-based Practice Center reports.

Requests for Single Reprints: Parminder Raina, PhD, Department of Clinical Epidemiology & Biostatistics, McMaster University, DTC Room 306, 1280 Main Street West, Hamilton, Ontario L8S 4L8, Canada.

Current Author Addresses: Dr. Santaguida: Department of Clinical Epidemiology & Biostatistics, McMaster University, DTC Room 309, 1280 Main Street West, Hamilton, Ontario L8S 4L8, Canada.

Dr. Helfand: Oregon Health & Science University, Mail Code BICC, 3181 SW Sam Jackson Park Road, Portland, OR 97239.

Dr. Raina: Department of Clinical Epidemiology & Biostatistics, McMaster University, DTC Room 306, 1280 Main Street West, Hamilton, Ontario L8S 4L8, Canada.




This article has been cited by other articles:


Home page
CirculationHome page
B. K. Nallamothu, R. A. Hayward, and E. R. Bates
Beyond the Randomized Clinical Trial: The Role of Effectiveness Studies in Evaluating Cardiovascular Therapies
Circulation, September 16, 2008; 118(12): 1294 - 1303.
[Full Text] [PDF]


Home page
Stat Methods Med ResHome page
G. Salanti, J. P. Higgins, A. Ades, and J. P. Ioannidis
Evaluation of networks of randomized trials
Statistical Methods in Medical Research, June 1, 2008; 17(3): 279 - 301.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
M. Helfand, S. Morton, E. Guallar, and C. Mulrow
A Guide to This Supplement
Ann Intern Med, June 21, 2005; 142(12_Part_2): 1033 - 1034.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. Chou and M. Helfand
Challenges in Systematic Reviews That Assess Treatment Harms
Ann Intern Med, June 21, 2005; 142(12_Part_2): 1090 - 1099.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. Hartling, F. A. McAlister, B. H. Rowe, J. Ezekowitz, C. Friesen, and T. P. Klassen
Challenges in Systematic Reviews of Therapeutic Devices and Procedures
Ann Intern Med, June 21, 2005; 142(12_Part_2): 1100 - 1111.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2005 by the American College of Physicians.